Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.4580
-0.0051 (-1.10%)
At close: Jul 25, 2025, 4:00 PM
0.4400
-0.0180 (-3.93%)
After-hours: Jul 25, 2025, 7:19 PM EDT

Athira Pharma Statistics

Total Valuation

Athira Pharma has a market cap or net worth of $17.88 million. The enterprise value is -$17.67 million.

Market Cap17.88M
Enterprise Value -17.67M

Important Dates

The next estimated earnings date is Monday, August 4, 2025, after market close.

Earnings Date Aug 4, 2025
Ex-Dividend Date n/a

Share Statistics

Athira Pharma has 39.04 million shares outstanding. The number of shares has increased by 1.42% in one year.

Current Share Class 39.04M
Shares Outstanding 39.04M
Shares Change (YoY) +1.42%
Shares Change (QoQ) +0.88%
Owned by Insiders (%) 14.09%
Owned by Institutions (%) 23.03%
Float 24.94M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.48
P/TBV Ratio 0.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.26, with a Debt / Equity ratio of 0.03.

Current Ratio 7.26
Quick Ratio 6.68
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -110.70% and return on invested capital (ROIC) is -67.00%.

Return on Equity (ROE) -110.70%
Return on Assets (ROA) -55.53%
Return on Invested Capital (ROIC) -67.00%
Return on Capital Employed (ROCE) -206.79%
Revenue Per Employee n/a
Profits Per Employee -$3.07M
Employee Count26
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -86.12% in the last 52 weeks. The beta is 2.99, so Athira Pharma's price volatility has been higher than the market average.

Beta (5Y) 2.99
52-Week Price Change -86.12%
50-Day Moving Average 0.34
200-Day Moving Average 0.43
Relative Strength Index (RSI) 65.56
Average Volume (20 Days) 282,407

Short Selling Information

The latest short interest is 1.03 million, so 2.65% of the outstanding shares have been sold short.

Short Interest 1.03M
Short Previous Month 1.32M
Short % of Shares Out 2.65%
Short % of Float 4.15%
Short Ratio (days to cover) 4.25

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -78.62M
Pretax Income -113.45M
Net Income -79.75M
EBITDA -77.65M
EBIT -78.62M
Earnings Per Share (EPS) -$2.06
Full Income Statement

Balance Sheet

The company has $36.67 million in cash and $1.12 million in debt, giving a net cash position of $35.55 million or $0.91 per share.

Cash & Cash Equivalents 36.67M
Total Debt 1.12M
Net Cash 35.55M
Net Cash Per Share $0.91
Equity (Book Value) 37.33M
Book Value Per Share 0.96
Working Capital 34.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.03 million and capital expenditures -$28,000, giving a free cash flow of -$86.06 million.

Operating Cash Flow -86.03M
Capital Expenditures -28,000
Free Cash Flow -86.06M
FCF Per Share -$2.20
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Athira Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.42%
Shareholder Yield -1.42%
Earnings Yield -445.97%
FCF Yield -481.28%

Analyst Forecast

The average price target for Athira Pharma is $11.25, which is 2,356.33% higher than the current price. The consensus rating is "Buy".

Price Target $11.25
Price Target Difference 2,356.33%
Analyst Consensus Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1